Valeant Eyeing Dermatology, Dentistry for M&A: CEO

March 19 (Bloomberg) -- Mike Pearson, chief executive officer of Valeant Pharmaceuticals International Inc., talks about the company's acquisition and growth strategy. He speaks with Stephanie Ruhle and Matt Miller on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Most Recent Videos

Qatar to Invest in U.S. Tech, Health Care, Real Estate
25:17 - Jan. 29 -- Qatar's Finance Minister Ali Shareef Al Emadi talks about investment strategy in the U.S. and the impact of slumping oil prices on the country. He speaks with Betty Liu on Bloomberg Television's "In the Loop."
  • Markets Respond to Alibaba’s Earnings, Shares Fall
  • Jobless Claims Plunge to 15-Year Low of 265,000
  • Jeffrey Gundlach Sees Fed on Brink of Big Mistake